Cart
sales@molnova.com
Acetylaconitine
CAS No. 77181-26-1
Acetylaconitine( Acetylaconitine | 3-Acetylaconitine )
Catalog No. M19096 CAS No. 77181-26-1
Analgesic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 104 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 389 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcetylaconitine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnalgesic activity.
-
DescriptionAnalgesic activity.
-
In VitroFlaconitine has been demonstrated to suppress TNF-α induced NF-κB activation and is considered as a diester-diterpenoid-type NF-κB inhibitor Flaconitine (3-Acetylaconitine)is evaluated for its cytotoxic activity against human leukemic P388 cells using the SRB (Sulforhodamine B) method, with Etoposide as the positive control. The cell growth inhibitory potency of Flaconitine is expressed as IC50 (μM) Value. Flaconitine exhibits moderately cytotoxic activity with an IC50 of 18.6 μM.
-
In Vivo——
-
SynonymsAcetylaconitine | 3-Acetylaconitine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number77181-26-1
-
Formula Weight687.77
-
Molecular FormulaC36H49NO12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (72.70 mM)
-
SMILESCCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC(=O)C)OC)OC)OC(=O)C)COC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(1R)-(?)-Myrtenal ...
(1R)-(?)-Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats.
-
JMJD6 inhibitor WL12
2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl- is a first-in-class JMJD6 inhibitor and was shown to be able to suppress JMJD6-dependent cancer cell proliferation including cervical and liver cancer cells.
-
(-)-Sparteine
Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.
